Interferon-α and Lamivudine Combination Therapy of Children with Chronic Hepatitis B Infection Who Were Interferon-α Nonresponders
Pediatric Infectious Disease Journal, ISSN: 0891-3668, Vol: 23, Issue: 5, Page: 466-468
2004
- 14Citations
- 3Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations14
- Citation Indexes13
- 13
- CrossRef6
- Policy Citations1
- 1
- Captures3
- Readers3
Article Description
Greater than one-half of children with chronic hepatitis B infection are nonresponders to interferon-α (IFN-α). The aim of this study was to investigate the efficacy of lamivudine (LMV) and IFN-α combination therapy in these children. Nineteen children were given LMV alone for 3 months; then IFN-α was added to LMV for 6 months. Virologic response was achieved in seven (36.8%) patients. LMV and IFN-α combination therapy may represent an effective treatment option.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=2442506605&origin=inward; http://dx.doi.org/10.1097/01.inf.0000122611.11236.42; http://www.ncbi.nlm.nih.gov/pubmed/15131475; http://journals.lww.com/00006454-200405000-00019; https://dx.doi.org/10.1097/01.inf.0000122611.11236.42; https://journals.lww.com/pidj/Fulltext/2004/05000/Interferon___and_Lamivudine_Combination_Therapy_of.19.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know